OnKure Therapeutics, Inc. - Class A Common Stock (OKUR)

About OnKure Therapeutics, Inc. - Class A Common Stock (OKUR)

OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.

OnKure Therapeutics, Inc. - Class A Common Stock News